Literature DB >> 15019429

Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration.

Drake Morgan1, David C S Roberts.   

Abstract

The process of addiction in humans involves a transition from recreational drug use to compulsive drug-taking. To understand or study this behavioral phenomenon from a neurobiological perspective, behavioral models that reflect this process are necessary. Data from typical (restricted access) self-administration procedures demonstrate a stable pattern of responding over time, and thus fail to capture the transitional phases of this process. Here we describe the development of a model that incorporates self-administration-induced changes in the reinforcing efficacy of cocaine, assessed using a progressive ratio schedule of reinforcement to probe the 'motivational' state of the animal. To date we have identified two necessary conditions for the development of this sensitization: extended access to cocaine and a deprivation period. This model, in conjunction with recently developed tools to characterize neurochemical and epigenetic changes, will provide a better understanding of the neurobiological bases of the addiction process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019429     DOI: 10.1016/j.neubiorev.2003.11.004

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  40 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed.

Authors:  Yu Liu; David C S Roberts; Drake Morgan
Journal:  Eur J Neurosci       Date:  2005-07       Impact factor: 3.386

3.  Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys.

Authors:  Paul W Czoty; Beth A Reboussin; Tonya L Calhoun; Susan H Nader; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2007-01-10       Impact factor: 4.530

4.  Effects of cocaine hydrolase on cocaine self-administration under a PR schedule and during extended access (escalation) in rats.

Authors:  Marilyn E Carroll; Yang Gao; Stephen Brimijoin; Justin J Anker
Journal:  Psychopharmacology (Berl)       Date:  2010-10-23       Impact factor: 4.530

Review 5.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

6.  The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors.

Authors:  Mark A Smith; Jennifer L Greene-Naples; Megan A Lyle; Jordan C Iordanou; Jennifer N Felder
Journal:  J Pharmacol Exp Ther       Date:  2009-04-29       Impact factor: 4.030

7.  The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine.

Authors:  Mark A Smith; Jennifer L Greene-Naples; Jennifer N Felder; Jordan C Iordanou; Megan A Lyle; Katherine L Walker
Journal:  J Pharmacol Exp Ther       Date:  2009-04-29       Impact factor: 4.030

8.  Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Drake Morgan; Mark A Smith; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

10.  Two modes of intense cocaine bingeing: increased persistence after social defeat stress and increased rate of intake due to extended access conditions in rats.

Authors:  Isabel M H Quadros; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.